Continuous Infusion Cisplatin and Etoposide Chemotherapy for Cancer of Unknown Primary Site (CUPS) in Taiwan, a Region with a High Prevalence of Endemic Viral Infections

Abstract

Etoposide and cisplatin combination chemotherapy has modest activity in patients with extensive CUPS and, at the schedule and dosage given, it is associated with moderate toxicity.